- Previous Close
0.5020 - Open
0.5720 - Bid --
- Ask 0.6000 x --
- Day's Range
0.4850 - 0.5720 - 52 Week Range
0.0035 - 0.5720 - Volume
2,551,067 - Avg. Volume
0 - Market Cap (intraday)
1.057M - Beta (5Y Monthly) 0.51
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Mar 24, 2025 - Mar 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Oscillate plc is a venture capital and private equity firm specializing in special situations, growth capital investments in fledging companies. It seeks to invest in listed or unlisted securities through debt or equity. The firm seeks to make investments across sectors including natural resources and technology. It also invests in medical psychedelic; medicinal cannabis market in companies, projects, or products that are either progressing medicinal or therapeutic cannabis research, or that are in the process of product development. Within medicinal cannabis sector, it primarily invests in nutraceuticals, CBD oils, dietary supplements, cosmetic products that contain cannabis or hemp, or the cultivation of cannabis and its derivative strains. Within medical psychedelic sector investments encompass the development of potential treatments for mental health issues, which include drug-resistant depression, anxiety, addiction, and post-traumatic stress disorder. It may take minority position to 100 per cent ownership in its portfolio companies. Oscillate plc was founded on November 27, 2006 and is based in London, United Kingdom.
www.oscillateplc.com3
Full Time Employees
November 30
Fiscal Year Ends
Sector
Industry
Recent News: MUSH.AQ
View MorePerformance Overview: MUSH.AQ
Trailing total returns as of 1/27/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MUSH.AQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MUSH.AQ
View MoreValuation Measures
Market Cap
1.21M
Enterprise Value
-1.03M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.26
Price/Book (mrq)
0.55
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-5.19%
Return on Equity (ttm)
-28.98%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-747.08k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.24M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--